https://www.marketscreener.com/quote/stock/HALOZYME-THERAPEUTICS-INC-50245/news/Halozyme-Therapeutics-Announces-FDA-Has-Accepted-Biologics-License-Application-for-Fixed-Dose-Subc-30066205/?utm_source=telegram&utm_medium=social&utm_campaign=share